| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rocuronium | FAERS: 8 | US FAERS | |
| 2 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 3 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 4 | Fluticasone | FAERS: 1 | US FAERS | |
| 5 | Glycopyrronium | FAERS: 1 | US FAERS | |
| 6 | QVA149 | FAERS: 1 | US FAERS | |
| 7 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 8 | indacaterol | FAERS: 1 | US FAERS | |
| 9 | Lorazepam | OFFSIDES | ||
| 10 | Nateglinide | OFFSIDES | ||
| 11 | Pamidronate | OFFSIDES | ||
| 12 | Ribavirin | OFFSIDES | ||
| 13 | Triamterene | OFFSIDES | ||
| 14 | Zoledronic Acid | OFFSIDES | ||
| 15 | ciclesonide | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | dolasetron | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.